IVZ vs HST
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 25, 2026
IVZ
64.0
AI Score
VS
IVZ Wins
HST
62.1
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | IVZ | HST | Winner |
|---|---|---|---|
| Revenue | 3.57B | 3.29B | IVZ |
| Net Income | 558.00M | 731.00M | HST |
| Net Margin | 15.6% | 22.3% | HST |
| Operating Income | 697.40M | 612.00M | IVZ |
| ROE | 4.5% | 11.4% | HST |
| ROA | 2.0% | 5.5% | HST |
| Total Assets | 27.47B | 13.25B | IVZ |
| Cash | 915.40M | 1.95B | HST |
Relative Price Performance (Last 90 Days)
IVZ 1M: -2.6%
· 3M: +11.0%
HST 1M: +4.0%
· 3M: -3.6%
Current Technical Phase
IVZ
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
HST
NeutralHold
Mixed signals - no dominant trend phase, RSI 51
Fundamentals Snapshot
| Metric | IVZ | HST |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.3 | 21.3 |
| Trailing P/E | — | 15.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.2% | 0.2% |
| EPS | -0.68 | 1.49 |
| Dividend Yield | 0.03% | 0.04% |
Frequently Asked Questions
Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.